⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGEN News
Oragenics Inc.
ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION
globenewswire.com
OGEN
Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia
globenewswire.com
OGEN
Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy
globenewswire.com
OGEN
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program
globenewswire.com
OGEN
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care
globenewswire.com
OGEN
Oragenics Q3 2025 Shareholder Update
businesswire.com
OGEN